Current and Novel Inhibitors of HIV Protease

The design, development and clinical success of HIV protease inhibitors represent one of the most remarkable achievements of molecular medicine. This review describes all nine currently available FDA-approved protease inhibitors, discusses their pharmacokinetic properties, off-target activities, sid...

Descripción completa

Detalles Bibliográficos
Autores principales: Pokorná, Jana, Machala, Ladislav, Řezáčová, Pavlína, Konvalinka, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185513/
https://www.ncbi.nlm.nih.gov/pubmed/21994591
http://dx.doi.org/10.3390/v1031209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185513/
https://www.ncbi.nlm.nih.gov/pubmed/21994591
http://dx.doi.org/10.3390/v1031209

Ejemplares similares